FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000795486> ?p ?o ?g. }

• W2000795486 endingPage "9" @default.
• W2000795486 startingPage "1" @default.
• W2000795486 abstract "Highly selective inhibitors of cyclooxygenase-2, such as rofecoxib, are hypothesized to have an improved gastrointestinal tolerability and safety profile compared with non-selective NSAIDs, which inhibit cyclooxygenase-1 and cyclooxygenase-2 non-selectively. This paper reviews data from randomized, double-blind, placebo-controlled studies which investigated the effects of rofecoxib and NSAIDs on the human gastrointestinal tract. In healthy subjects, rofecoxib 25 mg and 50 mg daily had no effect on gastric mucosal prostaglandin synthesis, whilst naproxen 1000 mg daily caused a 70% reduction. Therapeutic doses of rofecoxib 25 mg and 50 mg daily did not increase intestinal permeability or faecal blood loss in healthy subjects, whereas increases in both measures were seen with indometacin 150 mg or ibuprofen 2400 mg. A supra-therapeutic dose of rofecoxib (250 mg) given daily for 7 days did not induce an increase in gastroduodenal erosions in healthy subjects, whilst increased numbers of erosions were found in subjects given ibuprofen 2400 mg or aspirin 2600 mg. The endoscopic findings in healthy subjects were confirmed in two 6-month clinical studies involving 1516 patients with osteoarthritis; the incidences of ulcers following rofecoxib 25 mg or 50 mg daily were similar to placebo and less than ibuprofen 2400 mg. The advantage of rofecoxib over NSAIDs in these studies appears to translate into clinically relevant benefits; an analysis of 5435 patients with osteoarthritis found a significantly lower incidence of gastrointestinal perforations, ulcers and bleeds in patients taking rofecoxib compared with patients taking NSAIDs. Overall, the findings from these studies suggest that, as a result of cyclooxygenase-1 sparing, rofecoxib is significantly less gastrotoxic than non-selective NSAIDs, and may not differ from placebo." @default.
• W2000795486 created "2016-06-24" @default.
• W2000795486 creator A5016425613 @default.
• W2000795486 creator A5021135644 @default.
• W2000795486 creator A5021675273 @default.
• W2000795486 creator A5029978655 @default.
• W2000795486 creator A5045120095 @default.
• W2000795486 creator A5068343283 @default.
• W2000795486 date "2001-01-17" @default.
• W2000795486 modified "2023-10-17" @default.
• W2000795486 title "The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans" @default.
• W2000795486 cites W1968219794 @default.
• W2000795486 cites W1981662925 @default.
• W2000795486 cites W1981816788 @default.
• W2000795486 cites W2010673118 @default.
• W2000795486 cites W2034468337 @default.
• W2000795486 cites W2038410983 @default.
• W2000795486 cites W2044750065 @default.
• W2000795486 cites W2052022429 @default.
• W2000795486 cites W2054154014 @default.
• W2000795486 cites W2080197694 @default.
• W2000795486 cites W2083464592 @default.
• W2000795486 cites W2089107052 @default.
• W2000795486 cites W2105318758 @default.
• W2000795486 cites W2115578029 @default.
• W2000795486 cites W2115679325 @default.
• W2000795486 cites W2117227343 @default.
• W2000795486 cites W2123366546 @default.
• W2000795486 cites W2124643108 @default.
• W2000795486 cites W2138698403 @default.
• W2000795486 cites W61709055 @default.
• W2000795486 doi "https://doi.org/10.1046/j.1365-2036.2001.00894.x" @default.
• W2000795486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11136272" @default.
• W2000795486 hasPublicationYear "2001" @default.
• W2000795486 type Work @default.
• W2000795486 sameAs 2000795486 @default.
• W2000795486 citedByCount "41" @default.
• W2000795486 countsByYear W20007954862013 @default.
• W2000795486 crossrefType "journal-article" @default.
• W2000795486 hasAuthorship W2000795486A5016425613 @default.
• W2000795486 hasAuthorship W2000795486A5021135644 @default.
• W2000795486 hasAuthorship W2000795486A5021675273 @default.
• W2000795486 hasAuthorship W2000795486A5029978655 @default.
• W2000795486 hasAuthorship W2000795486A5045120095 @default.
• W2000795486 hasAuthorship W2000795486A5068343283 @default.
• W2000795486 hasBestOaLocation W20007954861 @default.
• W2000795486 hasConcept C126322002 @default.
• W2000795486 hasConcept C142724271 @default.
• W2000795486 hasConcept C181199279 @default.
• W2000795486 hasConcept C185592680 @default.
• W2000795486 hasConcept C197934379 @default.
• W2000795486 hasConcept C204787440 @default.
• W2000795486 hasConcept C27081682 @default.
• W2000795486 hasConcept C2776164576 @default.
• W2000795486 hasConcept C2776467144 @default.
• W2000795486 hasConcept C2777628954 @default.
• W2000795486 hasConcept C2778115740 @default.
• W2000795486 hasConcept C2778375690 @default.
• W2000795486 hasConcept C2778582115 @default.
• W2000795486 hasConcept C2779296319 @default.
• W2000795486 hasConcept C2779689624 @default.
• W2000795486 hasConcept C2779944601 @default.
• W2000795486 hasConcept C2909020919 @default.
• W2000795486 hasConcept C42219234 @default.
• W2000795486 hasConcept C55493867 @default.
• W2000795486 hasConcept C71924100 @default.
• W2000795486 hasConcept C90924648 @default.
• W2000795486 hasConcept C98274493 @default.
• W2000795486 hasConceptScore W2000795486C126322002 @default.
• W2000795486 hasConceptScore W2000795486C142724271 @default.
• W2000795486 hasConceptScore W2000795486C181199279 @default.
• W2000795486 hasConceptScore W2000795486C185592680 @default.
• W2000795486 hasConceptScore W2000795486C197934379 @default.
• W2000795486 hasConceptScore W2000795486C204787440 @default.
• W2000795486 hasConceptScore W2000795486C27081682 @default.
• W2000795486 hasConceptScore W2000795486C2776164576 @default.
• W2000795486 hasConceptScore W2000795486C2776467144 @default.
• W2000795486 hasConceptScore W2000795486C2777628954 @default.
• W2000795486 hasConceptScore W2000795486C2778115740 @default.
• W2000795486 hasConceptScore W2000795486C2778375690 @default.
• W2000795486 hasConceptScore W2000795486C2778582115 @default.
• W2000795486 hasConceptScore W2000795486C2779296319 @default.
• W2000795486 hasConceptScore W2000795486C2779689624 @default.
• W2000795486 hasConceptScore W2000795486C2779944601 @default.
• W2000795486 hasConceptScore W2000795486C2909020919 @default.
• W2000795486 hasConceptScore W2000795486C42219234 @default.
• W2000795486 hasConceptScore W2000795486C55493867 @default.
• W2000795486 hasConceptScore W2000795486C71924100 @default.
• W2000795486 hasConceptScore W2000795486C90924648 @default.
• W2000795486 hasConceptScore W2000795486C98274493 @default.
• W2000795486 hasIssue "1" @default.
• W2000795486 hasLocation W20007954861 @default.
• W2000795486 hasLocation W20007954862 @default.
• W2000795486 hasOpenAccess W2000795486 @default.
• W2000795486 hasPrimaryLocation W20007954861 @default.
• W2000795486 hasRelatedWork W2030674475 @default.
• W2000795486 hasRelatedWork W2045966064 @default.
• W2000795486 hasRelatedWork W2078054293 @default.

• next